Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
11:00
WEAA0101
Chidamide reactivates and diminishes latent HIV-1 DNA in patients on suppressive antiretroviral therapy
Wen Kang, Tangdu Hospital affiliated to The Fourth Military Medical University, China
Abstract
Slides
11:15
WEAA0102
The antiretroviral CCR5-inhibitor maraviroc effectively reverses HIV latency by phosphorylation of Nf-κB
Jori Symons, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Australia
Abstract
11:30
WEAA0103
Activation of latent HIV and SIV RNA transcription in vitro and in vivo in ART suppressed SIV-infected rhesus macaques by the Ingenol-based protein kinase C agonist, GSK445A
Afam Okoye, Oregon Health and Science University, United States
Abstract
11:45
WEAA0104
The RNA-binding proteins, SRP14 and HMGB3 play a crucial role in controlling HIV replication and latency
Georges Khoury, Peter Doherty Institute, Australia
Abstract
12:00
WEAA0105
Using the PPARg antagonism to block/lock HIV reactivation in Th17 cells
Petronela Ancuta, Universite de Montreal and CHUM Research Centre, Canada
Abstract
Slides
12:15
WEAA0108LB
The majority of the replication-competent virus in the latent reservoir originates from viruses circulating near the time of ART initiation
Sarah B. Joseph, University of North Carolina at Chapel Hill, United States
Abstract
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT